Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date of authorisation: 25/10/2005, Revision: 48, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 29 November 2023 - 16:53

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date of authorisation: 25/10/2005, Revision: 48, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/xolair

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters